RxSight, Inc. Debt-to-equity in % from Q1 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
RxSight, Inc. quarterly Debt-to-equity history and growth rate from Q1 2022 to Q3 2025.
  • RxSight, Inc. Debt-to-equity for the quarter ending September 30, 2025 was 12.1 %, a 0.92% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

RxSight, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 12.1 +0.11 +0.92% Sep 30, 2025
Q2 2025 12.1 +0.02 +0.17% Jun 30, 2025
Q1 2025 12.1 -3.44 -22.1% Mar 31, 2025
Q4 2024 12 -10.1 -45.6% Dec 31, 2024
Q3 2024 12 -19.9 -62.4% Sep 30, 2024
Q2 2024 12.1 -32.1 -72.6% Jun 30, 2024
Q1 2024 15.5 -37.6 -70.8% Mar 31, 2024
Q4 2023 22.1 -32.9 -59.8% Dec 31, 2023
Q3 2023 31.8 -16.3 -33.8% Sep 30, 2023
Q2 2023 44.2 +2.45 +5.87% Jun 30, 2023
Q1 2023 53.1 -165 -75.7% Mar 31, 2023
Q4 2022 55 Dec 31, 2022
Q3 2022 48.1 Sep 30, 2022
Q2 2022 41.7 Jun 30, 2022
Q1 2022 219 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.